Sandbox:Sahar: Difference between revisions
No edit summary |
No edit summary |
||
Line 83: | Line 83: | ||
! style="background: #FFFF00; width: 150px;" | Recomendacations !! style="background: #FFFF00; width: 150px;" | Class !! style="background: #FFFF00; width: 150px;" | Level !! style="background: #FFFF00; width: 150px;" | References | ! style="background: #FFFF00; width: 150px;" | Recomendacations !! style="background: #FFFF00; width: 150px;" | Class !! style="background: #FFFF00; width: 150px;" | Level !! style="background: #FFFF00; width: 150px;" | References | ||
|- | |- | ||
! colspan="4" |History and clinical assessment | ! colspan="4" align="left" |History and clinical assessment | ||
|- | |- | ||
! style="padding: 5px 5px; background: #FFFFE0; " |In all patients with suspected | ! style="padding: 5px 5px; background: #FFFFE0; " align="left" |In all patients with suspected | ||
AAS, pre-test probability | AAS, pre-test probability | ||
Line 100: | Line 100: | ||
| style="padding: 5px 5px; background: #FFFFE0;" align="center" | | | style="padding: 5px 5px; background: #FFFFE0;" align="center" | | ||
|- | |- | ||
! colspan="4" | Laboratory testing | ! colspan="4" align="left" | Laboratory testing | ||
|- | |- | ||
! style="padding: 5px 5px; background: #FFFFE0; " align="left" |In case of suspicion of AAS, | ! style="padding: 5px 5px; background: #FFFFE0; " align="left" |In case of suspicion of AAS, | ||
Line 115: | Line 115: | ||
| | | | ||
|- | |- | ||
! style="padding: 5px 5px; background: #F5F5F5; " |In case of low clinical | ! style="padding: 5px 5px; background: #F5F5F5; " align="left" |In case of low clinical | ||
probability of AAS, negative D-dimer | probability of AAS, negative D-dimer | ||
Line 128: | Line 128: | ||
| | | | ||
|- | |- | ||
! style="padding: 5px 5px; background: #FFFFE0; " |In case of intermediate clinical | ! style="padding: 5px 5px; background: #FFFFE0; " align="left" |In case of intermediate clinical | ||
probability of AAS with a | probability of AAS with a | ||
Line 141: | Line 141: | ||
| | | | ||
|- | |- | ||
! style="padding: 5px 5px; background: #F5F5F5; " |In patients with high probability | ! style="padding: 5px 5px; background: #F5F5F5; " align="left" |In patients with high probability | ||
(risk score 2 or 3) of AD, | (risk score 2 or 3) of AD, | ||
Line 152: | Line 152: | ||
| | | | ||
|- | |- | ||
! colspan="4" |Imaging | ! colspan="4" align="left" |Imaging | ||
|- | |- | ||
!TTE is recommended as an | ! style="padding: 5px 5px; background: #F5F5F5; " align="left" |TTE is recommended as an | ||
initial imaging investigation. | initial imaging investigation. | ||
Line 161: | Line 161: | ||
! | ! | ||
|- | |- | ||
!In unstabled patients with a | ! style="padding: 5px 5px; background: #F5F5F5; " align="left" |In unstabled patients with a | ||
suspicion of AAS, the following | suspicion of AAS, the following | ||
Line 184: | Line 184: | ||
! | ! | ||
|- | |- | ||
!In stable patients with a | ! style="padding: 5px 5px; background: #F5F5F5; " align="left" |In stable patients with a | ||
suspicion of AAS, the | suspicion of AAS, the | ||
Line 214: | Line 214: | ||
! | ! | ||
|- | |- | ||
!In case of initially negative | ! style="padding: 5px 5px; background: #F5F5F5; " align="left" |In case of initially negative | ||
imaging with the persistence of | imaging with the persistence of | ||
Line 227: | Line 227: | ||
! | ! | ||
|- | |- | ||
!Chest X-ray maybe | ! style="padding: 5px 5px; background: #F5F5F5; " align="left" |Chest X-ray maybe | ||
considered in cases of low | considered in cases of low | ||
Line 236: | Line 236: | ||
! | ! | ||
|- | |- | ||
!In case of uncomplicated | ! style="padding: 5px 5px; background: #F5F5F5; " align="left" |In case of uncomplicated | ||
Type B AD treated medically, | Type B AD treated medically, |
Revision as of 03:31, 25 December 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recomendacations | Class | Level | References |
---|---|---|---|
History and clinical assessment | |||
In all patients with suspected
AAS, pre-test probability assessment is recommended, according to the patient’s condition, symptoms, and clinical features. |
I | B | |
Laboratory testing | |||
In case of suspicion of AAS,
the interpretation of biomarkers should always be considered along with the pretest clinical probability. |
IIa | B | |
In case of low clinical
probability of AAS, negative D-dimer levels should be considered as ruling out the diagnosis. |
IIa | C | |
In case of intermediate clinical
probability of AAS with a positive (point-of-care) D-dimer test, further imaging tests should be considered. |
IIa | B | |
In patients with high probability
(risk score 2 or 3) of AD, testing of D-dimers is not recommended. |
III | C | |
Imaging | |||
TTE is recommended as an
initial imaging investigation. |
I | C | |
In unstabled patients with a
suspicion of AAS, the following imaging modalities are recommended according to local availability and expertise: |
|||
TOE | I | C | |
CT | I | C | |
In stable patients with a
suspicion of AAS, the following imaging modalities are recommended (or should be considered) according to local availability and expertise: |
|||
CT | I | C | |
MRI | I | C | |
TOE | IIa | C | |
In case of initially negative
imaging with the persistence of suspicion of AAS, repetitive imaging (CT or MRI) is recommended. |
I | C | |
Chest X-ray maybe
considered in cases of low clinical probability of AAS. |
IIb | C | |
In case of uncomplicated
Type B AD treated medically, repeated imaging (CT or MRI)e during the first days is recommended. |
I | C |